Inventor
BANDIERA TIZIANO
IT43 patents
⚠️ This page may combine multiple inventors who share the name “BANDIERA TIZIANO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
PHARMACIA & UPJOHN SPA
13 patentsUS5731313AMar 24, 1998
Use of anthracyclinone derivatives in amyloidosis
PHARMACIA & UPJOHN SPA18 citations92
US6194422B1Feb 27, 2001
Anthracycline derivatives
PHARMACIA & UPJOHN SPA7 citations73
US6096888AAug 1, 2000
Anthracyclinone derivatives and their use in amyloidosis
PHARMACIA & UPJOHN SPA10 citations73
US5998615ADec 7, 1999
Anthracyclinone derivatives
PHARMACIA & UPJOHN SPA13 citations73
US5985887ANov 16, 1999
Aza-anthracyclinone derivatives
PHARMACIA & UPJOHN SPA8 citations73
US6750215B2Jun 15, 2004
Substituted benzoxazines as integrin antagonists
PHARMACIA & UPJOHN SPA2 citations62
US6103700AAug 15, 2000
Fluoro labelled anthracyclinone and anthracycline derivatives
PHARMACIA & UPJOHN SPA3 citations62
US5968955AOct 19, 1999
Disubstituted piperidine derivatives as neuroprotective agents
PHARMACIA & UPJOHN SPA4 citations62
US6284896B1Sep 4, 2001
Abeo-ergoline derivatives as 5HT1A ligands
PHARMACIA & UPJOHN SPA2 citations61
US6087371AJul 11, 2000
Heterocyclyl-ergoline derivatives as 5-HT1A receptor ligands
PHARMACIA & UPJOHN SPA4 citations59
US6794385B2Sep 21, 2004
Benzoxazine derivatives useful as integrin receptor antagonists
PHARMACIA & UPJOHN SPA1 citations52
US6268362B1Jul 31, 2001
Amino anthracyclinone derivatives and their use in the treatment of amyloidosis
PHARMACIA & UPJOHN SPA0 citations52
US6316451B1Nov 13, 2001
Heterocyclyl anthracyclinone derivatives
PHARMACIA & UPJOHN SPA0 citations41
FONDAZIONE ST ITALIANO TECNOLOGIA
10 patentsUS12492193B2Dec 9, 2025
Pyrazole derivatives for the treatment of cystic fibrosis
FONDAZIONE ST ITALIANO TECNOLOGIA0 citations57
US11597723B2Mar 7, 2023
Pyrazole derivatives for the treatment of cystic fibrosis
FONDAZIONE ST ITALIANO TECNOLOGIA0 citations57
US10745407B2Aug 18, 2020
Heterocyclic derivatives for the treatment of cystic fibrosis
FONDAZIONE ST ITALIANO TECNOLOGIA1 citations56
US10364242B2Jul 30, 2019
Modulation of N-acylethanolamine-hydrolysing acid amidase (NAAA) for disease treatment
FONDAZIONE ST ITALIANO TECNOLOGIA0 citations50
US10968225B2Apr 6, 2021
Compounds and compositions for the treatment of cystic fibrosis
FONDAZIONE ST ITALIANO TECNOLOGIA0 citations45
US9949968B2Apr 24, 2018
Diarylalkylamine REV-ERB antagonists and their use as medicaments
FONDAZIONE ST ITALIANO TECNOLOGIA0 citations45
US11999734B2Jun 4, 2024
Compounds and compositions for the treatment of cystic fibrosis
FONDAZIONE ST ITALIANO TECNOLOGIA0 citations44
US12391680B2Aug 19, 2025
Compounds and compositions for the treatment of cystic fibrosis
FONDAZIONE ST ITALIANO TECNOLOGIA0 citations43
US9828352B2Nov 28, 2017
Phenyl carbamates and their use as inhibitors of the fatty acid amide hydrolase (FAAH) enzyme and modulators of the D3 dopamine receptor (D3DR)
FONDAZIONE ST ITALIANO TECNOLOGIA0 citations36
US10865194B2Dec 15, 2020
Therapeutically active bicyclic-sulphonamides and pharmaceutical compositions
FONDAZIONE ST ITALIANO TECNOLOGIA0 citations30
UNIV CALIFORNIA
6 patentsUS9822068B2Nov 21, 2017
Inhibitors of fatty acid amide hydrolase (FAAH) enzyme with improved oral bioavailability and their use as medicaments
UNIV CALIFORNIA2 citations73
US9745255B2Aug 29, 2017
Meta-substituted biphenyl peripherally restricted FAAH inhibitors
UNIV CALIFORNIA2 citations70
US9353075B2May 31, 2016
Disubstituted beta-lactones as inhibitors of N-acylethanolamine acid amidase (NAAA)
UNIV CALIFORNIA3 citations70
US10435355B2Oct 8, 2019
Inhibitors of fatty acid amide hydrolase (FAAH) enzyme with improved oral bioavailability and their use as medicaments
UNIV CALIFORNIA1 citations62
US9908848B2Mar 6, 2018
Amide derivatives of lactam based N-acylethanolamine acid amidase (NAAA) inhibitors
UNIV CALIFORNIA1 citations48
US9828338B2Nov 28, 2017
Carbamate derivatives of lactam based N-acylethanolamine acid amidase (NAAA) inhibitors
UNIV CALIFORNIA1 citations46
BANDIERA TIZIANO
4 patentsUS8114865B2Feb 14, 2012
Indazole derivatives as kinase inhibitors for the treatment of cancer
BANDIERA TIZIANO22 citations89
US8173659B2May 8, 2012
Substituted pyrazolo[4,3-C]pyridine derivatives active as kinase inhibitors
BANDIERA TIZIANO0 citations50
US8461193B2Jun 11, 2013
Substituted pyrrolo-pyrazole derivatives active as kinase inhibitors
BANDIERA TIZIANO0 citations49
US9012487B2Apr 21, 2015
Bicyclo-pyrazoles active as kinase inhibitors
BANDIERA TIZIANO0 citations48